1 November 2023
Kelso Group Holdings Plc ("Kelso' or the "Company")
Transaction in Own Shares
The Company announces that, on 31 October 2023, it purchased 1,200,000 ordinary shares of one pence each in the capital of the Company ("the Repurchased Shares") at a price of 2.0 pence per Ordinary Share (the "Repurchase").
The Repurchase equates to approximately 0.38 per cent of the issued Ordinary Shares and was undertaken in accordance with the terms of the general authority to make market purchases of Ordinary Shares granted to the Company by its shareholders at its Annual General Meeting on 24 May 2023. The Repurchase was executed on the London Stock Exchange through the Company's broker, Zeus Capital Limited.
Application will be made for the Repurchased Shares to be cancelled.
Following the Repurchase and the cancellation, the number of issued Ordinary Shares with voting rights in the Company is 312,975,000. This figure represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
About Kelso
Kelso was established in 2022 to identify, engage and unlock trapped value in the UK stock market. Kelso's strategy is to invest in situations where there is an anomaly between the intrinsic value and prospects of a company and its stock market valuation. Kelso will, in particular, look for situations where it believes the sum of the parts of a business is greater than the current value.
For further information please contact:
Kelso Group Holdings plc | +44 (0) 75 4033 3933 |
John Goold, Chief Executive Officer Mark Kirkland, Chief Financial Officer Jamie Brooke, Chief Investment Officer | |
| |
| |
Zeus (Broker) | +44 (0) 20 3829 5000 |
Nick Cowles, Ed Beddows (Investment Banking) Ben Robertson (Corporate Broking) | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.